Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

DYNAMO

Financiado

Modelling and dynamic assessment of integrated health and care pathways enhancin...

Modelling and dynamic assessment of integrated health and care pathways enhancing response capacity of health systems DYNAMO will result in a lean and powerful solution enabling quick, data-driven and platform-independent planning of care pathways for situations where health system functions are threatened. This solution will allow EU health care... ver más

28/02/2026

EMPIRICA

5M€

Presupuesto del proyecto: 5M€

Líder del proyecto

EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 9 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-11-25

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-HLTH-2022-CARE-08-02: Pre-commercial research and innovation procurement (PCP) for building the resilience of health care systems in the context of recovery

I+D

Cerrada hace 2 años

0% 100% 100%

9 Participantes

EMPIRICA

508.75K€ | Lider

KLINIKUM DER UNIVERSITAET ZU...

140.75K€ | Participante

SCMA

210.00K€ | Participante

Proyectos interesantes

HealthPros Healthcare Performance Intelligence Professionals 3M€ Cerrado

EUIN2015-62574 PLATAFORMA DE MODELOS PREDICTIVOS PARA LA PREVENCION Y GESTI... 10K€ Cerrado

PID2020-113723RB-C22 METODOS DE GRAFOS DE CONOCIMIENTO PARA MODELOS DE MINERIA DE... 149K€ Cerrado

TIN2017-85949-C2-1-R INFRAESTRUCTURA Y TECNOLOGIAS DE INTEROPERABILIDAD PARA APLI... 75K€ Cerrado

PID2020-113723RB-C21 DESARROLLO Y EXPLOTACION INTEGRADOS DE MODELOS DE MINERIA DE... 125K€ Cerrado

PSI2008-02019 COMO MEJORAR LA COMPRENSION Y COMUNICACION DE INFORMACION SO... 88K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 39 meses Fecha Inicio: 2022-11-25
Fecha Fin: 2026-02-28

Presupuesto del proyecto 5M€

Descripción del proyecto DYNAMO will result in a lean and powerful solution enabling quick, data-driven and platform-independent planning of care pathways for situations where health system functions are threatened. This solution will allow EU health care systems to build resilience and respond to public health threats better than they can today. DYNAMO brings together five procurers from Italy, Portugal, Spain, Greece and the United Kingdom that not only see the need for such a solution but are willing to act on it now. They will set up a collaborative demand-side initiative to create the economies of scale and early adoption cases required to build momentum for DYNAMO. As a strategic planning tool, DYNAMO will guide stakeholders in concept development, data modelling, process design and implementation planning. DYNAMO will be able to reliably inform medium-term investment planning to adapt existing processes and infrastructures (incl. IT systems). More specifically, DYNAMO will be a socio-technical system to 1. Efficiently adapt service delivery processes to shocks and structural changes 2. Share and integrate cross-sectoral data to accurately forecast outcomes and impacts of alternative pathway configurations 3. Facilitate task planning and skills matching in times of crises The Buyers Group includes health and care organisations and authorities representing diverse health care systems and settings, thus reflecting the requirements of different national health care ecosystems that DYNAMO will have to meet. Suppliers will be rigorously evaluated after each procurement phase, comprising: (I) an Open Market Consultation; (II) specification of architecture and system aligned to requirements of health and care professionals, IT planners, decision makers; (III) prototype development and testing with end-users; (IV) evaluation of implementation fidelity and tool performance, output feasibility in terms of validity and applicability of the generated pathways as well as (V) overall cost-effectiveness.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores